Literature DB >> 23079234

Lacunar infarcts in deep white matter are associated with higher and more fluctuating depressive symptoms during three years follow-up.

Anne M Grool1, Lotte Gerritsen, Nicolaas P A Zuithoff, Willem P T M Mali, Yolanda van der Graaf, Mirjam I Geerlings.   

Abstract

BACKGROUND: Disruption of frontal-subcortical circuits by cerebral small-vessel disease is thought to predispose to depression characterized by motivational symptoms. We examined the influence of lacunar infarcts and white matter lesions (WML) on severity and course of depressive symptoms during 3 years follow-up.
METHODS: Within the SMART-Medea study, analyses were performed in 650 patients with symptomatic atherosclerotic disease (62±9 years). Volumetric WML measures (deep and periventricular) were obtained with 1.5T magnetic resonance imaging at baseline; infarcts were rated visually. Depressive symptoms were assessed with Patient Health Questionnaire-9 at baseline and during five follow-up times and categorized into motivational and mood scores.
RESULTS: Using generalized estimating equation models, a relation between lacunar infarcts in deep white matter and an increased severity (mean difference=1.47, 95% confidence interval .33-2.60) and more fluctuating course (p value interaction infarcts * time=.04) of depressive symptoms during follow-up was found, adjusted for age, sex, education, vascular risk, and cognition. This relation was primarily driven by motivational symptoms. Lacunar infarcts were not associated with severity or course of depressive symptoms. Deep WML were associated with a more fluctuating but not more severe course of depressive symptoms. Excluding patients with major depressive disorder did not change the results.
CONCLUSIONS: In patients with symptomatic atherosclerotic disease and relatively mild depressive symptoms, depressive symptoms, characteristic of motivational problems, remained higher during 3 years follow-up in patients with lacunar infarcts in deep white matter and that symptom severity fluctuated over time.
Copyright © 2013 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23079234     DOI: 10.1016/j.biopsych.2012.08.024

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  12 in total

1.  Brain Structural Markers and Caregiving Characteristics as Interacting Correlates of Caregiving Strain.

Authors:  Stephen F Smagula; Scott Beach; Andrea L Rosso; Anne B Newman; Richard Schulz
Journal:  Am J Geriatr Psychiatry       Date:  2017-02-21       Impact factor: 4.105

2.  Cerebral Small Vessel Disease and Association With Higher Incidence of Depressive Symptoms in a General Elderly Population: The AGES-Reykjavik Study.

Authors:  Thomas T van Sloten; Sigurdur Sigurdsson; Mark A van Buchem; Caroline L Phillips; Palmi V Jonsson; Jie Ding; Miranda T Schram; Tamara B Harris; Vilmundur Gudnason; Lenore J Launer
Journal:  Am J Psychiatry       Date:  2015-03-03       Impact factor: 18.112

Review 3.  Association of Microvascular Dysfunction With Late-Life Depression: A Systematic Review and Meta-analysis.

Authors:  Marnix J M van Agtmaal; Alfons J H M Houben; Frans Pouwer; Coen D A Stehouwer; Miranda T Schram
Journal:  JAMA Psychiatry       Date:  2017-07-01       Impact factor: 21.596

4.  Associations between arterial stiffness, depressive symptoms and cerebral small vessel disease: cross-sectional findings from the AGES-Reykjavik Study.

Authors:  Thomas T van Sloten; Gary F Mitchell; Sigurdur Sigurdsson; Mark A van Buchem; Palmi V Jonsson; Melissa E Garcia; Tamara B Harris; Ronald M A Henry; Andrew S Levey; Coen D A Stehouwer; Vilmundur Gudnason; Lenore J Launer
Journal:  J Psychiatry Neurosci       Date:  2016-04       Impact factor: 6.186

5.  Apathy in small vessel cerebrovascular disease is associated with deficits in effort-based decision making.

Authors:  Youssuf Saleh; Campbell Le Heron; Pierre Petitet; Michele Veldsman; Daniel Drew; Olivia Plant; Ursula Schulz; Arjune Sen; Peter M Rothwell; Sanjay Manohar; Masud Husain
Journal:  Brain       Date:  2021-05-07       Impact factor: 15.255

6.  Depression in silent lacunar infarction: a cross-sectional study of its association with location of silent lacunar infarction and vascular risk factors.

Authors:  Ri-Han Wu; Qiang Li; Yan Tan; Xue-Yuan Liu; Jing Huang
Journal:  Neurol Sci       Date:  2014-04-22       Impact factor: 3.307

7.  Vascular depression consensus report - a critical update.

Authors:  Howard J Aizenstein; Andrius Baskys; Maura Boldrini; Meryl A Butters; Breno S Diniz; Manoj Kumar Jaiswal; Kurt A Jellinger; Lev S Kruglov; Ivan A Meshandin; Milija D Mijajlovic; Guenter Niklewski; Sarah Pospos; Keerthy Raju; Kneginja Richter; David C Steffens; Warren D Taylor; Oren Tene
Journal:  BMC Med       Date:  2016-11-03       Impact factor: 8.775

8.  Depressive symptoms related to low fractional anisotropy of white matter underlying the right ventral anterior cingulate in older adults with atherosclerotic vascular disease.

Authors:  Kelly R Bijanki; Joy T Matsui; Helen S Mayberg; Vincent A Magnotta; Stephan Arndt; Hans J Johnson; Peg Nopoulos; Sergio Paradiso; Laurie M McCormick; Jess G Fiedorowicz; Eric A Epping; David J Moser
Journal:  Front Hum Neurosci       Date:  2015-07-15       Impact factor: 3.169

9.  Psychological and personality factors in type 2 diabetes mellitus, presenting the rationale and exploratory results from The Maastricht Study, a population-based cohort study.

Authors:  Fleur E P van Dooren; Johan Denollet; Frans R J Verhey; Coen D A Stehouwer; Simone J S Sep; Ronald M A Henry; Stef P J Kremers; Pieter C Dagnelie; Nicolaas C Schaper; Carla J H van der Kallen; Annemarie Koster; Frans Pouwer; Miranda T Schram
Journal:  BMC Psychiatry       Date:  2016-01-27       Impact factor: 3.630

10.  Involvement of the reward network is associated with apathy in cerebral small vessel disease.

Authors:  Danuta M Lisiecka-Ford; Daniel J Tozer; Robin G Morris; Andrew J Lawrence; Thomas R Barrick; Hugh S Markus
Journal:  J Affect Disord       Date:  2018-02-15       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.